|
Sign In to gain access to subscriptions and/or personal tools.
|
Salivary Lysozyme and Prevalent Hypertension
M. Qvarnstrom1,
S. Janket2,*,
J.A. Jones2,
P. Nuutinen3,
A.E. Baird4,
M.E. Nunn5,
T.E. Van Dyke6 and
J.H. Meurman7
1 Otorhinolaryngology/Oral and Maxillofacial Surgery, Kuopio University, Kuopio, Finland;
2 General Dentistry,
5 Health Policy and Health Services Research, and
6 Periodontology and Oral Biology, Boston University School of Dental Medicine, 100 East Newton Street, Rm. G-619, Boston, MA 02118, USA;
3 Cardiothoracic Surgery, Kuopio University Hospital, Kuopio, Finland;
4 National Institute of Neurologic Disorders and Stroke, NIH, Bethesda, MD, USA; and
7 University of Helsinki, Institute of Dentistry and Helsinki University Central Hospital, Helsinki, Finland

View larger version (24K):
[in this window]
[in a new window]
|
Figure 1. Conceptual model for the relationship of salivary lysozyme and endothelial dysfunction. TNF- , Tumor necrosis factor-alpha; IL-1B, Interleukin-1B; IL-6, Interleukin-6. **Reproduced with permission (Janket et al., 2007a).
|
|
Journal of Dental Research, Vol. 87, No. 5,
480-484 (2008)
DOI: 10.1177/154405910808700507

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|